HBIO vs LW · rev $22.7M vs P/E 21, rev $6.61B
Harvard Bioscience Inc (HBIO) versus Lamb Weston Holdings Inc (LW) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Lamb Weston Holdings Inc (LW) is a packaged foods company listed on US.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Latest reported LW revenue for 2026-05-31 was $6.61B. Net income was $290.0M. Revenue was up 2.5% from 2025-05-25 to 2026-05-31. LW currently screens at market cap $7.40B and trailing P/E 20.6.
HBIO currently screens at market cap $20.3M. LW currently screens at market cap $7.40B and trailing P/E 20.6.
Not investment advice. Open the HBIO and LW stock pages for the full models.
Not investment advice.